OSE Immunotherapeutics
Biotech, drug development, immuno-oncology, immuno-inflammation
- B2B
About OSE Immunotherapeutics
Develops first-in-class assets in immuno-oncology and immuno-inflammation, including therapeutic cancer vaccines, monoclonal antibodies for solid tumors, ulcerative colitis, and chronic inflammation, and transplant.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Nantes, Brittany, France
- Founded
- 2012
- Revenue
- €2.7MFY2025, publicly reported
- Website
- ose-immuno.com
OSE Immunotherapeutics at a glance
OSE Immunotherapeutics is a B2B company in the Biotechnology Research industry, headquartered in Nantes, Brittany, France.
OSE Immunotherapeutics was founded in 2012.
OSE Immunotherapeutics has 51–250 employees.
OSE Immunotherapeutics's revenue is €2.7M (FY2025, publicly reported).
Selling to companies like OSE Immunotherapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies